Gallstones are common in the United States, affecting an estimated 1 in 7 adults. Fortunately, they are asymptomatic in up to 80% of cases, and current guidelines do not recommend cholecystectomy unless they cause symptoms. Laparoscopic cholecystectomy is the standard treatment for symptomatic gallstones, acute cholecystitis, and gallstone pancreatitis.

I nadequate bowel preparation (IBP) at the time of inpatient colonoscopy is common and associated with increased length of stay and cost of care. 1 The factors that contribute to IBP can be categorized into those that are modifiable and those that are nonmodifiable. While many factors have been associated with IBP, studies have been limited by small sample size or have combined inpatient/outpatient populations, thus limiting generalizability. 1-5 Moreover, most factors associated with IBP, such as socioeconomic status, male gender, increased age, and comorbidities, are nonmodifiable. No studies have explicitly focused on modifiable risk factors, such as medication use, colonoscopy timing, or assessed the potential impact of modifying these factors.In a large, multihospital system, we examine the frequency of IBP among inpatients undergoing colonoscopy along with factors associated with IBP. We attempted to identify modifiable risk factors that were associated with IBP.

Background:The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. Methods:We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were included.Results: This review describes the most common abnormalities encountered on echocardiography, LUS, and CMR in patients infected with COVID-19.

No abstract

The manifestations of COVID-19 as outlined by echocardiography, lung ultrasound (LUS) and cardiac magnetic resonance (CMR) imaging are yet to be fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, LUS and CMR. We queried PubMed, EMBASE and Web of Science for relevant articles. Original studies and case series were included. This review describes the most common abnormalities encountered on echocardiography, LUS and CMR in patients infected with COVID-19.